Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 776 - 800 of 1069 in total
Chlorsulfaquinoxaline has been used in trials studying the treatment of Lung Cancer and Colorectal Cancer.
Investigational
Matched Categories: … Sulfur Compounds …
GLPG-0974 is under investigation in clinical trial NCT01721980 (Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects).
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. Suramin...
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Sulforaphane is under investigation for the treatment of Autism Spectrum Disorder. It is a naturally occurring isothiocyanate found in high concentration in a variety of broccoli.
Investigational
Matched Categories: … Sulfur Compounds …
Upamostat has been used in trials studying the treatment of Pancreatic Cancer.
Investigational
Matched Categories: … Sulfur Compounds …
Giripladib is under investigation in clinical trial NCT00396955 (A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee).
Investigational
Matched Categories: … Sulfur Compounds …
GSK-2981278 is under investigation in clinical trial NCT03004846 (A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis).
Investigational
Matched Categories: … Sulfur Compounds …
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Experimental
Vet approved
Matched Categories: … Sulfur Compounds …
Vet approved
Matched Categories: … Sulfur Compounds …
Investigational
Vet approved
Matched Categories: … Sulfur Compounds …
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers).
Investigational
Matched Categories: … Sulfur Compounds …
Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).
Investigational
Matched Categories: … Sulfur Compounds …
Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
Investigational
Matched Categories: … Sulfur Compounds …
Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).
Investigational
Matched Categories: … Sulfur Compounds …
Investigational
Matched Categories: … Sulfur Compounds …
XL765 is an orally available small molecule that has been shown in preclinical studies to selectively inhibit the activity of phosphoinositide-3 kinase (PI3K) and mammalian target of rapamycin (mTOR). It is being developed by Exelixis, Inc.
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
CMX-2043 has been used in trials studying the treatment and prevention of Non STEMI, Unstable Angina, Stable Coronary Artery Disease, and Percutaneous Coronary Intervention.
Investigational
Matched Categories: … Sulfur Compounds …
Displaying drugs 776 - 800 of 1069 in total